Literature DB >> 28495983

Immunomodulation Is the Key to Cardiac Repair.

Tariq Hamid1, Sumanth D Prabhu2.   

Abstract

Entities:  

Keywords:  Editorials; cell therapy; immunomodulation; inflammation; mesenchymal stem cells; myocardial infarction

Mesh：

Substances：

Year:  2017        PMID： 28495983      PMCID： PMC5604853          DOI： 10.1161/CIRCRESAHA.117.310954

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  15 in total

1.  Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.

Authors:  Elaine Wan; Xin Yi Yeap; Shirley Dehn; Rachael Terry; Margaret Novak; Shuang Zhang; Shinichi Iwata; Xiaoqiang Han; Shunichi Homma; Konstantinos Drosatos; Jon Lomasney; David M Engman; Stephen D Miller; Douglas E Vaughan; John P Morrow; Raj Kishore; Edward B Thorp
Journal:  Circ Res       Date:  2013-07-08       Impact factor: 17.367

2.  Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction.

Authors:  Yiru Guo; Marcin Wysoczynski; Yibing Nong; Alex Tomlin; Xiaoping Zhu; Anna M Gumpert; Marjan Nasr; Senthikumar Muthusamy; Hong Li; Michael Book; Abdur Khan; Kyung U Hong; Qianhong Li; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2017-02-16       Impact factor: 17.165

3.  Neutrophil activation and survival are modulated by interaction with NK cells.

Authors:  Claudio Costantini; Alessandra Micheletti; Federica Calzetti; Omar Perbellini; Giovanni Pizzolo; Marco A Cassatella
Journal:  Int Immunol       Date:  2010-08-25       Impact factor: 4.823

4.  Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure.

Authors:  Shyam S Bansal; Mohamed Ameen Ismahil; Mehak Goel; Bindiya Patel; Tariq Hamid; Gregg Rokosh; Sumanth D Prabhu
Journal:  Circ Heart Fail       Date:  2017-03       Impact factor: 8.790

Review 5.  Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review.

Authors:  Patricia K Nguyen; June-Wha Rhee; Joseph C Wu
Journal:  JAMA Cardiol       Date:  2016-10-01       Impact factor: 14.676

6.  Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.

Authors:  Dror Luger; Michael J Lipinski; Peter C Westman; David K Glover; Julien Dimastromatteo; Juan C Frias; M Teresa Albelda; Sergey Sikora; Alex Kharazi; Grigory Vertelov; Ron Waksman; Stephen E Epstein
Journal:  Circ Res       Date:  2017-02-23       Impact factor: 17.367

7.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Authors:  Joshua M Hare; Jay H Traverse; Timothy D Henry; Nabil Dib; Robert K Strumpf; Steven P Schulman; Gary Gerstenblith; Anthony N DeMaria; Ali E Denktas; Roger S Gammon; James B Hermiller; Mark A Reisman; Gary L Schaer; Warren Sherman
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

8.  Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure.

Authors:  Hendrik B Sager; Maarten Hulsmans; Kory J Lavine; Marina B Moreira; Timo Heidt; Gabriel Courties; Yuan Sun; Yoshiko Iwamoto; Benoit Tricot; Omar F Khan; James E Dahlman; Anna Borodovsky; Kevin Fitzgerald; Daniel G Anderson; Ralph Weissleder; Peter Libby; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2016-07-21       Impact factor: 17.367

9.  Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: critical importance of the cardiosplenic axis.

Authors:  Mohamed Ameen Ismahil; Tariq Hamid; Shyam S Bansal; Bindiya Patel; Justin R Kingery; Sumanth D Prabhu
Journal:  Circ Res       Date:  2013-11-01       Impact factor: 17.367

Review 10.  Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors.

Authors:  F van den Akker; S C A de Jager; J P G Sluijter
Journal:  Mediators Inflamm       Date:  2013-12-10       Impact factor: 4.711
View more
  6 in total

Review 1.  Immune cell diversity contributes to the pathogenesis of myocarditis.

Authors:  Xiumeng Hua; Jiangping Song
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

2.  Mesenchymal Stem Cells Promote the Resolution of Cardiac Inflammation After Ischemia Reperfusion Via Enhancing Efferocytosis of Neutrophils.

Authors:  Zeyu Zhang; Hongzhen Tian; Chen Yang; Jixuan Liu; Huawei Zhang; Jinda Wang; Shunying Hu; Zhijun Sun; Kunlun He; Guanghui Chen
Journal:  J Am Heart Assoc       Date:  2020-02-21       Impact factor: 5.501

Review 3.  3D printing approaches for cardiac tissue engineering and role of immune modulation in tissue regeneration.

Authors:  Muhammad Qasim; Farhan Haq; Min-Hee Kang; Jin-Hoi Kim
Journal:  Int J Nanomedicine       Date:  2019-02-20

Review 4.  Turning regenerative technologies into treatment to repair myocardial injuries.

Authors:  Felicia Carotenuto; Laura Teodori; Anna Maria Maccari; Luciano Delbono; Giuseppe Orlando; Paolo Di Nardo
Journal:  J Cell Mol Med       Date:  2019-09-30       Impact factor: 5.310

Review 5.  Regenerative medicine technologies applied to transplant medicine. An update.

Authors:  Astgik Petrosyan; Filippo Montali; Andrea Peloso; Antonio Citro; Lori N Byers; Catherine La Pointe; Mara Suleiman; Alice Marchetti; Eoin P Mcneill; Allison L Speer; Wai Hoe Ng; Xi Ren; Benedetta Bussolati; Laura Perin; Paolo Di Nardo; Vincenzo Cardinale; Jerome Duisit; Alexandra Rose Monetti; John Richard Savino; Amish Asthana; Giuseppe Orlando
Journal:  Front Bioeng Biotechnol       Date:  2022-09-28

Review 6.  Biological, chemical and mechanical factors regulating migration and homing of mesenchymal stem cells.

Authors:  Renata Szydlak
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.